Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of EUR 3.44 billion. The enterprise value is 4.58 billion.

Market Cap	3.44B
Enterprise Value	4.58B

Important Dates

The next estimated earnings date is Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	74.36M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	50.84M

Valuation Ratios

The trailing PE ratio is 112.58 and the forward PE ratio is 48.25.

PE Ratio	112.58
Forward PE	48.25
PS Ratio	1.59
PB Ratio	6.77
P/TBV Ratio	n/a
P/FCF Ratio	23.23
P/OCF Ratio	12.72
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.00, with an EV/FCF ratio of 30.86.

EV / Earnings	149.55
EV / Sales	2.16
EV / EBITDA	17.00
EV / EBIT	51.96
EV / FCF	30.86

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.45.

Current Ratio	0.85
Quick Ratio	0.73
Debt / Equity	2.45
Debt / EBITDA	4.52
Debt / FCF	8.40
Interest Coverage	1.46

Financial Efficiency

Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 3.35%.

Return on Equity (ROE)	5.12%
Return on Assets (ROA)	2.70%
Return on Invested Capital (ROIC)	3.35%
Return on Capital Employed (ROCE)	5.60%
Revenue Per Employee	46,194
Profits Per Employee	651
Employee Count	47,256
Asset Turnover	1.04
Inventory Turnover	27.47

Taxes

In the past 12 months, Medicover AB has paid 10.60 million in taxes.

Income Tax	10.60M
Effective Tax Rate	28.27%

Stock Price Statistics

The stock price has increased by +21.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.18%
50-Day Moving Average	21.34
200-Day Moving Average	18.00
Relative Strength Index (RSI)	57.44
Average Volume (20 Days)	1,006

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of EUR 2.17 billion and earned 30.60 million in profits. Earnings per share was 0.20.

Revenue	2.17B
Gross Profit	476.40M
Operating Income	90.20M
Pretax Income	37.50M
Net Income	30.60M
EBITDA	188.20M
EBIT	90.20M
Earnings Per Share (EPS)	0.20

Full Income Statement

Balance Sheet

The company has 108.00 million in cash and 1.25 billion in debt, giving a net cash position of -1.14 billion.

Cash & Cash Equivalents	108.00M
Total Debt	1.25B
Net Cash	-1.14B
Net Cash Per Share	n/a
Equity (Book Value)	509.10M
Book Value Per Share	3.25
Working Capital	-84.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 270.90 million and capital expenditures -122.60 million, giving a free cash flow of 148.30 million.

Operating Cash Flow	270.90M
Capital Expenditures	-122.60M
Free Cash Flow	148.30M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 21.94%, with operating and profit margins of 4.15% and 1.41%.

Gross Margin	21.94%
Operating Margin	4.15%
Pretax Margin	1.73%
Profit Margin	1.41%
EBITDA Margin	8.67%
EBIT Margin	4.15%
FCF Margin	6.83%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.73%.

Dividend Per Share	0.15
Dividend Yield	0.73%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	n/a
Payout Ratio	58.82%
Buyback Yield	-0.35%
Shareholder Yield	0.38%
Earnings Yield	0.89%
FCF Yield	4.31%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	7